11 The European Association Medical devices Notified Bodies VISION on REVISION.

Slides:



Advertisements
Similar presentations
Module N° 4 – ICAO SSP framework
Advertisements

1 Welcome Safety Regulatory Function Handbook April 2006.
Organizational Governance
The National Standards and Quality System Jean-Louis Racine The World Bank Cambridge, England April 19, 2007 Knowledge Economy Forum VI Technology Acquisition.
European Commission Jacques McMillan Enterprise Directorate-General Legal aspects linked to internal market EUROPEAN CONFERENCE ON MARKET SURVEILLANCE.
EMS Checklist (ISO model)
The European Association Medical devices - Notified Bodies - Medical Device Survey 2013 data from 28 NBs.
WHO update on: Guidelines for the selection of RH medicines and prequalification of priority RH medicines Medicines Policy and Standards Health Technology.
The European Association of Medical device Notified Bodies
The European Association Medical devices
Medsafe – GMP update / release for supply / communicating quality issues Derek Fitzgerald Manager, Compliance Management 11 July 2013 RACI Pharmaceutical.
Prepared and presented by Paul French AJA Registrars Operations Director AJA are a multi-accredited International Certification Body based in Portishead.
Ensuring Better Services and Fair Value “Introduction and roadmap to implementation of ISO in Zambia’s water utilities” Kasenga Hara March 2015.
Conformity Assessment Practical Implications InterAgency Committee on Standards Policy June 2007 Gordon Gillerman Conformity Assessment Advisor Homeland.
GCP compliance for GenISIS  This presentation is intended for clinical staff involved in recruiting patients to the GenISIS (Genetics of Influenza Susceptibility.
Quality evaluation and improvement for Internal Audit
EU Vigilance New Manufacturer Incident Report Form Piloting arrangements.
Purpose of the Standards
CE marking Catriona Blake Team Manager, Imaging, acute and community care.
Medical Device Revisions Case Study Phil Brown 20th September 2012.
[Hayes, Dassen, Schilder and Wallage, Principles of Auditing An Introduction to ISAs, edition 2.1] © Pearson Education Limited 2007 Slide 5.1 Client Acceptance.
Overview of Medical Devices Sector Saudi Food and Drug Authority (Saudi Arabia) Dr. Saleh Al Tayyar Director General Medical Devices Sector Saudi Food.
Challenges of a Harmonized Global Safety Regime Jacques Repussard Director General IRSN IAEA 2007 Scientific Forum.
© Obelis s.a CODE OF CONDUCT of Authorised Representative services under the Council Directive 93/42/EEC, Directive 98/79/EC and Council Directive.
Revision of the Medical Device Directives The case of ‘Borderline’ Products used in a self-care context 48th AESGP Annual Meeting Nice, 6-8 June 2012 Laurent.
Ensuring Food Safety in Europe through Scientific Cooperation and Networking The Role of EFSA Carola Sondermann EFSA Polish Focal Point – Annual Experts.
The concept for a network of national Reference Laboratories for high risk IVDs – Results of the working group meeting 1.
A project implemented by the HTSPE consortium This project is funded by the European Union SECURITY AND CITIZENS SECURITY AND CITIZENSHIP CONSUMER
European Commission Rita L’ABBATE Legal aspects linked to internal market DG Enterprise and Industry MARKET SURVEILLANCE COMMUNITY FRAMEWORK UNECE “MARS”
28th Meeting of the Competent Authorities Matthias Neumann Federal Ministry of Health, Germany Cracow, 27th of October 2011 Central Management Committee:
“The Quality Infrastructure in Lebanon” Export Norms, Quality Control and Competitiveness FUTURE PROGRAMME Prepared By Ali Berro Director of Quality Programme.
The New Approach and GPSD. Council Resolution of 7 May 1985 on a new approach to technical harmonization and standards [OJ C136 of June 1985] New Approach.
Directorate General for Enterprise and Industry European Commission The New Legislative Framework - Market Surveillance UNECE “MARS” Group meeting Bratislava,
1 The Future Role of the Food and Veterinary Office M.C. Gaynor, Director, FVO EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL Directorate.
Proposal for a Regulation of the European Parliament and of the Council on medical devices and amending Directive 2001/83/EC, Regulation (EC) No 178/2002.
UPCOMING CHANGES TO IN-VITRO DIAGNOSTICS (IVDs) AND LABORATORY DEVELOPED TESTS (LDTs) REGULATIONS Moj Eram, PhD November 5, 2015.
European Commission REGULATORY MODEL OF THE EUROPEAN UNION Norbert ANSELMANN Head of Unit, ENTR G2, Standardisation Directorate.
organization – status 2015 – scheme – integrity program – strategy
The New Legislative Framework
Notified Body Problem Solving Warsaw, Poland 24/26 June 2004 Presented by Peter Hanmore For the benefit of business and people TAIEX Workshop on the Pressure.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 32 – Financial Control Bilateral screening:
Information Sharing for Integrated Care A 5 Step Blueprint.
Workshop on Accreditation of Bodies Certifying Medical Devices Kiev, November 2014.
ICAJ/PAB - Improving Compliance with International Standards on Auditing Planning an audit of financial statements 19 July 2014.
Medical Device Regulations in Canada; Key Challenges and International Initiatives.
CLAUDIA PANAIT TAIEX Expert – European Commission Legal Adviser Ministry of Health, ROMANIA.
THE OFFICE FOR REGISTRATION OF MEDICINAL PRODUCTS, MEDICAL DEVICES AND BIOCIDAL PRODUCTS Responsibility in the handling of medical devices.
Harmonised use of accreditation for assessing the competence of various Conformity Assessment Bodies Dr Andreas Steinhorst, EA ERA workshop 13 April 2016,
WORKSHOP ON ACCREDITATION OF BODIES CERTIFYING MEDICAL DEVICES INT MARKET TOPIC 6 CH 5 ISO MANAGEMENT RESPONSIBILITY Philippe Bauwin Medical.
Internal Audit Quality Assessment Guide
Workshop on conformity assessment procedures and certification of medical devices INT MARKT Kyiv, November 2011 Conformity assessment of medical.
Copyright © 2011 Pearson Canada Inc. Auditing: The Art and Science of Assurance Engagements Chapter 2: The Public Accounting Profession.
Health and Consumers Health and Consumers Introduction to the new Medical Device Regulations and their impact on medical software DG for Internal Market,
Clusters working group COM/CAMD New Regulations
Update on EU regulatory developments
Industry Implementation Priorities & Challenges COM/CAMD Stakeholders meeting on the new MD and IVD Regulations 9 March, 2017 John Brennan Director.
The European Association Medical devices
Nicole Denjoy COCIR Secretary General
The European Association of Medical device Notified Bodies
New European Medical Device Regulations – major changes that will affect all devices Rene van de Zande EMERGO | President & CEO
The EPSO Peer Evaluation of the Danish Health and Medicines Authority
03/12/2018 Update - EU Medical Device Regulation Utah Life Science Summit November 2015 Paul Brooks Senior Vice President Healthcare Solutions.
“Association Presentation
NEW MDR Regulatory Context. NEW MDR Regulatory Context.
Taking the STANDARDS Seriously
Raising the Standards in European Homeopathy
The European Association Medical devices
The European Association Medical devices
Conclusions from the Review of REACH
EUnetHTA Assembly May 2018.
Presentation transcript:

11 The European Association Medical devices Notified Bodies VISION on REVISION

2 Aims: Communication with –European Commission –Competent Authorities –Industry Promote technical and ethical standards Participate in improving the legal framework Contribute to harmonization Represent Notified Bodies TEAM-NB Team-NB-Presentation – Vision on Revision

Mandatory to sign for TEAM- NB members Available on website Changes and additions: –Extension to IVD –Unannounced visits –Product Verification –Supervisory Structure –Peer assessment 3 Raising the bar for Notified Bodies Team-NB-Presentation – Vision on Revision

Detailed content CoC V3.1 Implementation, enforcement and monitoring of the Code of Conduct –Auditor pool being contracted –Inspections starting after summer when transition is over –Annual self-evaluation on top Unannounced visits Qualification and Assignment of Notified Body Assessment Personnel Minimum time for Notified Body assessments Sampling of class IIa and IIb technical files Design Dossier Reviews Rules for subcontracting Rules for Certification Decisions 4 Team-NB-Presentation – Vision on Revision

Statement towards Daily Telegraph TEAM-NB members are committed to ensure the safety of Medical Devices on the EU market TEAM-NB members abide by regulatory and ethical aspects by law as well as on voluntary basis TEAM-NB members agree to be submitted to a strong and harmonized assessment and surveillance system by member states and commission TEAM-NB members are fully aware of their responsibility to ensure certification of medical devices complies with the Directives 5 Team-NB-Presentation – Vision on Revision

PMA versus enhanced Notified Body system Uniform strict requirement for notified bodies Uniform supervision by joint authorities, coordination COM Centralised and decentralised Market Approval no solution – will stifle innovation & promote consolidation The years that European patients benefit from early entry of products on the market are too valuable for our healthcare system to just throw it away Need to remove rotten apples from manufacturers, notified bodies as well as practitioners in unacceptable off label use and in not-reporting clinical problems with medical devices in the current system 6 Team-NB-Presentation – Vision on Revision

Single use - Reprocessing supportive of adding control to a largely unregulated area in-house reprocessing of single-use devices by health institutions same req.s as outsourced reprocessing No national deviations: safety and performance of the reprocessed device are not a choice but a need Reprocessable as basis adds too much risks to patients A list of single-use devices for critical use which can be reprocessed, decided by the Commission with oversight from Member States, will secure a high level of patient safety. SCENIHR could advise updating such list. 7 Team-NB-Presentation – Vision on Revision

Scope & Reclassifications Non-viable human material not substantially manipulated to be added (in line with USA) Products that contain viable organisms not to be excluded; as most products contain some Products that intentionally incorporate biological substances or organisms that are viable can be excluded Reclassifications to class III mostly oke 8 Team-NB-Presentation – Vision on Revision

intended to be ingested, inhaled or administered rectally or vaginally.... absorbed by or dispersed in the human body Inconsistencies in wording –implantable device means any device, including those that are partially or wholly absorbed, which is intended…… –Rule 6 All surgically invasive devices intended for transient use are in class IIa unless they:… – have a biological effect or are wholly or mainly absorbed in which case they are in class IIb,… –Rule 7 All surgically invasive devices intended for short-term use are in class IIa unless they:… have a biological effect or are wholly or mainly absorbed in which case they are in class III,… Inconsistency with special rule –Would include IVF Media for embryo storage, administered vaginally and dispersed by the body. This contradicts the proposal in the MDR to classify such products as class IIb. Inconsistency excluding some body orifices –administered via the eye, ear or nose Happy to keep IIa, IIb, III via rules 6-8 and special rules; borderline group can actively classify 9 Team-NB-Presentation – Vision on Revision

Traceability – Implant cards - Transparency Supportive of improved traceability requirements Supportive of introduction UDI Supportive of (electronic) implant cards, also for partial implants Supportive of good functioning accessible database Supportive of summary evaluation report for products with periodic safety update reporting 10 Team-NB-Presentation – Vision on Revision

Clinical trials and evidence Clarification of intent MemberState approving clin. trials Supportive of coordination on multi-country trials Clinical experts (relevant to the field) to be used for assessment of new and innovative high risk device - most of such clinicians will not be permanent staff, as the expertise is mostly available in practicing surgeons and professors. At least four years of practice in clinical field relevant to device under review Actively practicing surgery in field of application for min1 day a week, max 4 yrs ago Practicing in IMDRF countries, or having practiced there for a minimum of 4 years Demonstrated knowledge on reviewing, designing or conducting clinical trials Declaration listing what the clinician reviewed before (review CV tracking) 11 Team-NB-Presentation – Vision on Revision

Some further topics PMS/PMCF – support growing emphasis for notified bodies to review continuously - DIS ISO 13485:2014/15 MDCG to become an effective forum for decision-making –Include notified bodies in working groups cosmetic implants – either rule based or time-limited review of positive inclusion list – clinical benefit issues CTS helpful on top of harmonised standards if all stakeholders can contribute – e.g. Specification minimum aspects for clinical trials for new types of implants 12 Team-NB-Presentation – Vision on Revision

Last slide on notified body qualifications TEAM-NB members should arrange to be properly resourced with the necessary expertise Members state designation authorities should meet the same requirements in order to supervise appropriately TEAM-NB is of strong opinion that tightening up monitoring of notified bodies with assessments, audits and better communication is crucial to ensure a consistent level of scrutiny of manufacturers & devices across EU Qualification requirements for personnel involved in conformity assessment procedures to be described in more detail to ensure level playing field all over Europe 13 Team-NB-Presentation – Vision on Revision

14 Contacts Management: Gert Bos – president Hans Heiner Junker – vice president Guy Buijzen – assistant vice-president Aud Løken Eiklidh - treasurer Corinne Delorme – secretary Françoise Schlemmer -Director and Secretariat Team-NB-Presentation – Vision on Revision